NCT03718455View on ClinicalTrials.gov

Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes

NATerminatedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

October 30, 2018

Primary Completion Date

December 1, 2019

Study Completion Date

December 1, 2019

Conditions
Breast Cancer
Interventions
DEVICE

Axillary Magseed

The Magseed will replace the investigators' current clinical practice of using radioactive seeds in women receiving neoadjuvant chemotherapy.

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Mayo Clinic
All Listed Sponsors
lead

Mayo Clinic

OTHER

NCT03718455 - Evaluation of Magseed as Localization Device for Biopsy Proven Metastatic Axillary Lymph Nodes | Biotech Hunter | Biotech Hunter